Hongzhong Qiu - Guangzhou Baiyunshan Independent Non-Executive Director
GZPHF Stock | USD 2.88 0.00 0.00% |
Director
Mr. Qiu Hongzhong was Independent NonExecutive Director in GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED since June 28, 2010. He is a Professor in Guangzhou University of Chinese Medicine, China. since 2010.
Age | 56 |
Tenure | 14 years |
Phone | 86 20 6628 1218 |
Web | https://www.gybys.com.cn |
Guangzhou Baiyunshan Management Efficiency
The company has return on total asset (ROA) of 0.0356 % which means that it generated a profit of $0.0356 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1281 %, meaning that it generated $0.1281 on every $100 dollars invested by stockholders. Guangzhou Baiyunshan's management efficiency ratios could be used to measure how well Guangzhou Baiyunshan manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Richard Koo | Amphastar P | 77 | |
Rolf Classon | Catalent | 75 | |
Michael Barber | Catalent | 60 | |
Shmuel Cabilly | Redhill Biopharma | 66 | |
Martin Carroll | Catalent | 68 | |
William Doyle | Zoetis Inc | 52 | |
Judith Robertson | Durect | N/A | |
Jon Saxe | Durect | 81 | |
William Steere | Zoetis Inc | 83 | |
Gail Farfel | Durect | 53 | |
Peter Zippelius | Catalent | 41 | |
Donald Morel | Catalent | 63 | |
Dan Suesskind | Redhill Biopharma | 72 | |
Bronwen Evans | Cronos Group | 48 | |
Howard Lee | Amphastar P | 55 | |
Terrence Blaschke | Durect | 71 | |
Gregory Norden | Zoetis Inc | 62 | |
Thomas Penn | ANI Pharmaceuticals | 72 | |
Patrick Walsh | ANI Pharmaceuticals | 57 | |
Ira Kalfus | Redhill Biopharma | N/A | |
Lucier Gregory | Catalent | 50 |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0356 |
Guangzhou Baiyunshan Leadership Team
Elected by the shareholders, the Guangzhou Baiyunshan's board of directors comprises two types of representatives: Guangzhou Baiyunshan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guangzhou. The board's role is to monitor Guangzhou Baiyunshan's management team and ensure that shareholders' interests are well served. Guangzhou Baiyunshan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guangzhou Baiyunshan's outside directors are responsible for providing unbiased perspectives on the board's policies.
Changhai Wu, Vice General Manager, Executive Director and Member of Nomination and Remuneration Committee | ||
Zhang Chunbo, Deputy Director | ||
Jinxiang Liu, Independent Non-Executive Director | ||
Haiwen Huang, Deputy General Manager | ||
Yonghua Zhang, Independent Non-Executive Director | ||
Jun Yang, Vice Chairman | ||
Jianhui Pang, Secretary of the Board | ||
Juyan Liu, Ex Director | ||
Longde Huang, Independent Non-Executive Director | ||
Shanmin Li, Independent Non-Executive Director | ||
Wenqi Jiang, Independent Director | ||
Xiaoping Chu, Independent Director | ||
Xuezhen Huang, Secretary of the Board | ||
Weihong Wang, Independent Director | ||
Guangfeng Su, Deputy General Manager | ||
Mao Chen, Vice Chairman of the Board | ||
Chunbo Zhang, Deputy General Manager | ||
Chuyuan Li, Chairman and Chairman of Strategic Devel. and Investment Committee | ||
Hong Li, General Manager | ||
Haoshan Zheng, Deputy General Manager | ||
Xianrong Huang, Independent Director | ||
Jianxiong Zheng, Deputy Mang | ||
Hongzhong Qiu, Independent Non-Executive Director | ||
Yidong Ni, Director | ||
Ning Cheng, Executive Director and Member of Budget Committee |
Guangzhou Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Guangzhou Baiyunshan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0356 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 5.65 B | |||
Shares Outstanding | 219.9 M | |||
Shares Owned By Institutions | 33.99 % | |||
Price To Earning | 6.77 X | |||
Price To Book | 0.78 X | |||
Price To Sales | 0.11 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guangzhou Baiyunshan Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Guangzhou Baiyunshan information on this page should be used as a complementary analysis to other Guangzhou Baiyunshan's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Guangzhou Pink Sheet analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |